Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty

DE Mager, MA Mascelli, NS Kleiman… - … of Pharmacology and …, 2003 - ASPET
An integrated structural pharmacokinetic/pharmacodynamic (PK/PD) model was developed
for the glycoprotein IIb/IIIa antagonist abciximab administered to patients undergoing …
被引用次数：50 相关文章

Simultaneous Modeling of Abciximab Plasma Concentrations and ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty

DE Mager, MA Mascelli, NS Kleiman… - Journal of …, 2003 - pure.johnshopkins.edu
An integrated structural pharmacokinetic/pharmacodynamic (PK/PD) model was developed
for the glycoprotein IIb/IIIa antagonist abciximab administered to patients undergoing …

[引用][C] Simultaneous Modeling of Abciximab Plasma Concentrations and Ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty

DE Mager, MA Mascelli, NS Kleiman… - … of Pharmacology and …, 2003 - ASPET
249 words Introduction: 637 words Discussion: 1438 words Abbreviations: Div, intravenous
abciximab dose; Eb, residual ex vivo platelet aggregation in presence of maximum drug …

Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty.

DE Mager, MA Mascelli, NS Kleiman… - The Journal of …, 2003 - europepmc.org
An integrated structural pharmacokinetic/pharmacodynamic (PK/PD) model was developed
for the glycoprotein IIb/IIIa antagonist abciximab administered to patients undergoing …

Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty

DE Mager, MA Mascelli, NS Kleiman… - The Journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
An integrated structural pharmacokinetic/pharmacodynamic (PK/PD) model was developed
for the glycoprotein IIb/IIIa antagonist abciximab administered to patients undergoing …

[引用][C] Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty

DE MAGER, MA MASCELLI… - The Journal of …, 2003 - American Society for Pharmacology …